Gender does not matter: Add-on repetitive transcranial magnetic stimulation treatment for female methamphetamine dependents

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8:92:70-75. doi: 10.1016/j.pnpbp.2018.12.018. Epub 2018 Dec 31.

Abstract

Background: Repetitive transcranial magnetic stimulation (rTMS) targeting prefrontal cortex reduces craving in different types of drug addiction. However, most studies failed to elucidate the potential gender discrepancies for the treatment effects, due to the small percentage of female subjects enrolled. The present study prospectively recruited female methamphetamine dependents for TMS treatment.

Methods: Ninety female methamphetamine dependents were randomly assigned into the control group (routine addiction rehabilitation) or add-on 10 Hz group (routine addiction rehabilitation plus 20 times rTMS treatments). The craving scores to drug associated cues were examined as the primary outcome for this treatment.

Results: The results showed that add-on rTMS treatment was as well effective in female methamphetamine dependents, and the effect lasted for at least 30 days after treatment. Drug abuse history predicts the efficacy of chronic treatment, and the effects of TMS treatment was more pronounced in young, high-craving subjects.

Conclusions: Add-on high frequency rTMS treatment is as well tolerable and effective in female methamphetamine dependents.

Keywords: Addiction; Craving; Female; Gender; Methamphetamine; Transcranial magnetic stimulation.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Amphetamine-Related Disorders / rehabilitation*
  • Central Nervous System Stimulants / administration & dosage
  • Craving
  • Feasibility Studies
  • Female
  • Humans
  • Methamphetamine / administration & dosage
  • Middle Aged
  • Prefrontal Cortex
  • Sex Factors
  • Time Factors
  • Transcranial Magnetic Stimulation*
  • Treatment Outcome
  • Young Adult

Substances

  • Central Nervous System Stimulants
  • Methamphetamine